Revenue | ₹563.48Cr |
Net Profits | ₹48.88Cr |
Net Profit Margins | 8.67% |
Cohance Lifesciences Ltd’s revenue jumped 11.03% since last year same period to ₹563.48Cr in the Q1 2025-2026. On a quarterly growth basis, Cohance Lifesciences Ltd has generated -33.9% fall in its revenue since last 3-months.
Cohance Lifesciences Ltd’s net profit fell -35.15% since last year same period to ₹48.88Cr in the Q1 2025-2026. On a quarterly growth basis, Cohance Lifesciences Ltd has generated -59.41% fall in its net profits since last 3-months.
Cohance Lifesciences Ltd’s net profit margin fell -41.59% since last year same period to 8.67% in the Q1 2025-2026. On a quarterly growth basis, Cohance Lifesciences Ltd has generated -38.6% fall in its net profit margins since last 3-months.
The revenue for Cohance Lifesciences Ltd in the Q1 results 2025 was ₹563.48Cr.
The net profit for Cohance Lifesciences Ltd in the Q1 results 2025 was ₹48.88Cr.
The net profit margin for Cohance Lifesciences Ltd in the Q1 results 2025 was 8.67%.
The revenue for Cohance Lifesciences Ltd in the Q1 results 2024 was ₹507.49Cr.
The net profit for Cohance Lifesciences Ltd in the Q1 results 2024 was ₹75.37Cr.
The net profit margin for Cohance Lifesciences Ltd in the Q1 results 2024 was 14.85%.